Search

Get to know our Principal Investigator and team of researchers at Lux Lab 

Contact the Hilgemann Lab

The prevalence of obesity represents a major threat to human health globally. Obesity substantially increases the risk of various diseases such as type 2 diabetes, nonalcoholic fatty liver disease, hypertension, cardiovascular disease, and certain cancers.

Learn about the Hilgemann Lab's research

If you're interested in joining Lux Lab, please reach out to learn more about open positions.  

Our recent work identified a new mutant mouse, termed teeny, that exhibited growth retardation, lipodystrophy, extreme insulin resistance, severe diabetes with fasting glucose as high as 600-700 mg/dL, and fatty liver.

Publications for Zhao Zhang, Ph.D.

If you're interested in joining our team, please reach out to learn more about open positions at the Zhang Lab.  

In the Zhang Lab, we seek to understand the key molecular mechanisms to maintain energy balance in our body, with the long-term goal of creating novel therapeutic strategies.

Nonalcoholic fatty liver disease (NAFLD) is a condition in which excess fat is stored in the liver in people who drink little or no alcohol.